$2.45T
Total marketcap
$74.71B
Total volume
BTC 50.63%     ETH 14.83%
Dominance

Astec LifeSciences Limited ASTEC.NS Stock

1300 INR {{ price }} -0.080708% {{change_pct}}%
COUNTRY
India
Exchange
NSE
Market Cap
25.49B INR
LOW - HIGH [24H]
1266.5 - 1336 INR
VOLUME [24H]
120.9K INR
{{ volume }}
P/E Ratio
0
Earnings per share
-26.04 INR

Astec LifeSciences Limited Price Chart

Astec LifeSciences Limited ASTEC.NS Financial and Trading Overview

Astec LifeSciences Limited stock price 1300 INR
Previous Close 1376.95 INR
Open 1392 INR
Bid 1379.25 INR x 0
Ask 1381.5 INR x 0
Day's Range 1369.55 - 1399.95 INR
52 Week Range 1045 - 2288.8 INR
Volume 11.92K INR
Avg. Volume 53.36K INR
Market Cap 27.08B INR
Beta (5Y Monthly) 0.407876
PE Ratio (TTM) 106.160645
EPS (TTM) -26.04 INR
Forward Dividend & Yield 1.5 (0.11%)
Ex-Dividend Date July 20, 2023
1y Target Est 1580 INR

ASTEC.NS Valuation Measures

Enterprise Value 30.6B INR
Trailing P/E 106.160645
Forward P/E 26.509598
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 4.3107085
Price/Book (mrq) 6.4615207
Enterprise Value/Revenue 4.871
Enterprise Value/EBITDA 40.127

Trading Information

Astec LifeSciences Limited Stock Price History

Beta (5Y Monthly) 0.407876
52-Week Change -21.66%
S&P500 52-Week Change 20.43%
52 Week High 2288.8 INR
52 Week Low 1045 INR
50-Day Moving Average 1387.6 INR
200-Day Moving Average 1657.11 INR

ASTEC.NS Share Statistics

Avg. Volume (3 month) 53.36K INR
Avg. Daily Volume (10-Days) 44.14K INR
Shares Outstanding 19.61M
Float 5.59M
Short Ratio N/A
% Held by Insiders 71.52%
% Held by Institutions 12.39%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.5
Trailing Annual Dividend Yield 0.10%
5 Year Average Dividend Yield 19.00%
Payout Ratio 0.115
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2023
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End March 31, 2024

Profitability

Profit Margin 4.07%
Operating Margin (ttm) 6.78%
Gross Margin 36.12%
EBITDA Margin 12.13%

Management Effectiveness

Return on Assets (ttm) 2.83%
Return on Equity (ttm) 6.27%

Income Statement

Revenue (ttm) 6.28B INR
Revenue Per Share (ttm) 320.41 INR
Quarterly Revenue Growth (yoy) -53.40%
Gross Profit (ttm) N/A
EBITDA 762.54M INR
Net Income Avi to Common (ttm) 255.65M INR
Diluted EPS (ttm) 13.01
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 21.58M INR
Total Cash Per Share (mrq) 1.1 INR
Total Debt (mrq) 3.41B INR
Total Debt/Equity (mrq) 81.32 INR
Current Ratio (mrq) 0.948
Book Value Per Share (mrq) 213.75

Cash Flow Statement

Operating Cash Flow (ttm) 746.56M INR
Levered Free Cash Flow (ttm) -665016000 INR

Profile of Astec LifeSciences Limited

Country India
State N/A
City Mumbai
Address Godrej One
ZIP 400079
Phone 91 22 2518 8010
Website https://www.astecls.com
Industry Agricultural Inputs
Sector(s) Basic Materials
Full Time Employees N/A

Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. It manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic amines, pyridine derivatives, aromatic carboxylic acids, benzyl alcohols, ketones and benzophenones, and heterocyclic mercaptans; fluorinated aromatic, aliphatic, and heterocyclic intermediates; heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, heterocyclic sulfonyl chlorides, heterocyclic sulphonamides, heterocyclic carbamates, thiourium salts, alkyl and aryl chloroformates, substituted pyrimidine diones, and pyrazolones; and substituted 1,2- and 1,3- pyrimidines. The company's products also comprise pyrazolyl aromatic ketones, morpholine derivatives, aromatic azo compounds, substituted triazines, imidate ethers, mesylated intermediates, substituted epoxides, ketals and bromo ketals, aromatic and aliphatic ethers, cyclopropyl ethers, cyclopropyl aldehydes and ketones, conjugated ketones, acetophenone derivatives, pinacolone derivatives, aliphatic and aromatic carboxylic acids, aliphatic and aromatic acid chlorides, halogenated and non-halogenated anhydrides, aliphatic alkenes, and halo alkanes; and aliphatic and aromatic brominated derivatives, cyanides, esters, carboxamides, amines, and alcohols and diols. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.

Q&A For Astec LifeSciences Limited Stock

What is a current ASTEC.NS stock price?

Astec LifeSciences Limited ASTEC.NS stock price today per share is 1300 INR.

How to purchase Astec LifeSciences Limited stock?

You can buy ASTEC.NS shares on the NSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Astec LifeSciences Limited?

The stock symbol or ticker of Astec LifeSciences Limited is ASTEC.NS.

Which industry does the Astec LifeSciences Limited company belong to?

The Astec LifeSciences Limited industry is Agricultural Inputs.

How many shares does Astec LifeSciences Limited have in circulation?

The max supply of Astec LifeSciences Limited shares is 19.61M.

What is Astec LifeSciences Limited Price to Earnings Ratio (PE Ratio)?

Astec LifeSciences Limited PE Ratio is now.

What was Astec LifeSciences Limited earnings per share over the trailing 12 months (TTM)?

Astec LifeSciences Limited EPS is -26.04 INR over the trailing 12 months.

Which sector does the Astec LifeSciences Limited company belong to?

The Astec LifeSciences Limited sector is Basic Materials.